Table 1 Baseline characteristics of... | American Society of Hematology

Table 1

Baseline characteristics of participants who developed venous thromboembolism and those who did not: LITE

Baseline characteristic	N*	No VTE (n = 1047)	VTE (n = 462)	P
Age, y†	1509	62.3 (10.0)	62.9 (10.0)	.34
Male sex, %†	1509	43%	44%	.88
Black race, %†	1509	26%	27%	.92
Study, % ARIC†	1509	63%	59%	.22
BMI, kg/m²	1503	27.5 (5.0)	29.1 (5.6)	< .001
Diabetes	1498	11%	17%	.003
Factor VIII, %	1415	128 (38)	143 (48)	< .001
D-dimer, μg/mL	1494	0.59 (0.67)	0.73 (0.79)	< .001
Factor V Leiden heterozygote/homozygote, %	1413	3.0%	10.3%	< .001
Prothrombin 20210A heterozygote/homozygote, %	1417	2.1%	3.5%	.14
Factor IX, %	1498	144 (31)	147 (33)	.04
Factor X, %	1495	139 (35)	139 (36)	.88
Factor XI, %	1497	132 (36)	139 (37)	< .001
Factor XII, %	1494	141 (46)	143 (45)	.53
Factor XIII, %	1499	141 (39)	142 (42)	.65

Baseline characteristic	N*	No VTE (n = 1047)	VTE (n = 462)	P
Age, y†	1509	62.3 (10.0)	62.9 (10.0)	.34
Male sex, %†	1509	43%	44%	.88
Black race, %†	1509	26%	27%	.92
Study, % ARIC†	1509	63%	59%	.22
BMI, kg/m²	1503	27.5 (5.0)	29.1 (5.6)	< .001
Diabetes	1498	11%	17%	.003
Factor VIII, %	1415	128 (38)	143 (48)	< .001
D-dimer, μg/mL	1494	0.59 (0.67)	0.73 (0.79)	< .001
Factor V Leiden heterozygote/homozygote, %	1413	3.0%	10.3%	< .001
Prothrombin 20210A heterozygote/homozygote, %	1417	2.1%	3.5%	.14
Factor IX, %	1498	144 (31)	147 (33)	.04
Factor X, %	1495	139 (35)	139 (36)	.88
Factor XI, %	1497	132 (36)	139 (37)	< .001
Factor XII, %	1494	141 (46)	143 (45)	.53
Factor XIII, %	1499	141 (39)	142 (42)	.65

Values are mean (SD) or percent prevalence. P values are from the χ² or the t test.

Seven participants were counted as both a case and a control because of the sampling method.

Frequency matching variables.